Jessica Fessler

Title: Jessica Fessler: Innovator in Microbiome Biomarkers and Immunotherapy

Introduction

Jessica Fessler is a prominent inventor based in Chicago, IL (US). She has made significant contributions to the field of immunotherapy through her innovative research on microbiome biomarkers. Her work focuses on understanding how the microbiome can influence the effectiveness of immunotherapy treatments.

Latest Patents

Jessica Fessler holds a patent titled "Microbiome biomarkers immunotherapy responsiveness: diagnostic, prognostic and therapeutic uses thereof." This patent encompasses compositions and methods that utilize microbiome biomarkers to assess a subject's responsiveness or resistance to immunotherapy, particularly anti-PD1/PD-L1 therapy. The invention highlights the importance of the microbiome's composition in determining treatment outcomes and suggests methods to manipulate the microbiome to enhance therapeutic responses.

Career Highlights

Jessica is affiliated with The University of Chicago, where she conducts her research and collaborates with other experts in the field. Her work has garnered attention for its potential to improve patient outcomes in immunotherapy.

Collaborations

Jessica collaborates with notable colleagues, including Vyara Matson and Thomas F. Gajewski. Their combined expertise contributes to advancing research in immunotherapy and microbiome studies.

Conclusion

Jessica Fessler is a trailblazer in the intersection of microbiome research and immunotherapy. Her innovative patent and collaborative efforts at The University of Chicago position her as a key figure in enhancing treatment strategies for patients.